Market Definition 

Pelvic Floor Electric Stimulator is a non-surgical treatment for fecal and urinary incontinence. Pelvic Floor Electric Stimulator improve urinary frequency, urgency and incontinence, and increase the strength of the pelvic floor and vaginal muscles. Pelvic Floor Electric Stimulator is a painless and effective procedure. 

Global pelvic floor electric stimulator market is estimated to reach $XX million by 2026; growing at a CAGR of 11.4% till 2026. 

Market Dynamics 

Rising prevalence of urinary incontinence (UI) and fecal incontinence is a key driving factor of the market. The prevalence of UI increases with age. In 2018, over 423 million people are affected by urinary incontinence. According to Continence Foundation of Australia, around 5 million Australians experienced bladder or bowel control problems in 2018. Urinary incontinence affects 13% of Australian men and about 37% of Australian women in 2018. Faecal incontinence is a considerable problem for older people. Chronic fecal incontinence (FI) affects more than 20 million U.S adults. According to the Continence Foundation of Australia, Faecal incontinence affects 6% of Australian men and 10% of Australian women. However, the availability of pelvic floor electric stimulator alternatives might hamper market growth. Magnetic stimulation (MS) is an alternative technique for the treatment of urinary incontinence. Magnetic stimulation treatment is an approach to provide noninvasive, passive stimulation to the sacral roots or the pelvic floor. The Magnetic stimulation was approved by the United States Food and Drug Administration in 1998 for urinary incontinence. Moreover, increasing investment by the companies for research and development of pelvic floor electric stimulator would provide lucrative opportunities for the market in the coming years. 

Market Segmentation 

The global pelvic floor electric stimulator market is mainly classified based on application and end user. Application is further segmented into Urinary Incontinence, Neurodegenerative Diseases, and Sexual Dysfunction. By end user, the market is divided into Hospital, Clinics, and Homecare Setting.  

Urinary Incontinence was dominating the global pelvic floor electric stimulator market in 2019, owing to the rising prevalence of urinary incontinence (UI), the collaboration between companies for research and development of pelvic floor electric stimulator, and commercialization of regulatory approved pelvic floor electric stimulator for the treatment of urinary incontinence (UI). For instance, Atlantic Therapeutics has received clearance from the FDA for its electrical stimulator treatment for stress urinary incontinence (SUI). Atlantic Therapeutics receives FDA over-the-counter clearance for wearable pelvic floor muscle stimulator. 

Regional Analysis 

Based on geography, the global pelvic floor electric stimulator market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa. 

North America was dominating the pelvic floor electric stimulator market in 2019, due to the rising incidence of urinary incontinence (UI) and fecal incontinence in the North American regions, increasing research studies on pelvic floor electric stimulator by the companies, and launch of new pelvic floor electric stimulator. For instance, BewellConnect has introduced a new pelvic floor muscle trainer to help women with issues, including post-partum complications and incontinence. The MyPeriTens device is an electrical nerve stimulator and electrical muscle stimulator that is controlled through a smartphone app, allowing women to control the intensity and nature of the electrical signals delivered. 

Competitive landscape 

Major players operating in the pelvic floor electric stimulator industry include TensCare Ltd., Verity Medical Ltd, tic Medizintechnik GmbH & Co. KG, InControl Medical, The Prometheus Group, Laborie, Inc., Atlantic Therapeutics Ltd, ActivLife Technologies Pty Ltd, Zynex Medical, and Shenzhen XFT Medical Limited. 

The strategic agreement between companies to develop and market pelvic floor electric stimulator, commercialization of advanced pelvic floor electric stimulator, clinical studies on pelvic floor electric stimulator, rising investment by the companies to develop pelvic floor electric stimulator, and increasing regulatory approvals of pelvic floor electric stimulator are some of the strategies implemented by the key players. For instance, InControl Medical has received FDA clearance for its Attain over-the-counter, non-implantable muscle stimulator for urinary and bowel incontinence. The Attain system is used to treat women suffering from stress, urge, mixed urinary incontinence and bowel incontinence. 

Pelvic Floor Electric Stimulator Market Key Segments: 

By Application 

• Urinary Incontinence 
• Neurodegenerative Diseases 
• Sexual Dysfunction 

By End User 

• Hospital 
• Clinics 
• Homecare Setting 

Key Global Pelvic Floor Electric Stimulator Industry Players 

• TensCare Ltd. 
• Verity Medical Ltd 
• tic Medizintechnik GmbH & Co. KG 
• InControl Medical 
• The Prometheus Group 
• Laborie, Inc. 
• Atlantic Therapeutics Ltd 
• ActivLife Technologies Pty Ltd 
• Zynex Medical 
• Shenzhen XFT Medical Limited 

What Report Provides 

• Full in-depth analysis of the parent Industry 
• Important changes in market and its dynamics 
• Segmentation details of the market 
• Former, on-going, and projected market analysis in terms of volume and value 
• Assessment of niche industry developments 
• Market share analysis 
• Key strategies of major players 
• Emerging segments and regional growth potential